John Varian
CIK 1416176 · CEO · last filed 2026-01-09
John Varian is a CEO who has filed 68 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing, for SLS, was dated Jan 9, 2026. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $821.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$821.3K
6
68
-$2.49M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLS | Director | 72,900 | $7.83 | $570.8K | $0 | 10 | 2026-01-09 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | Director | — | $0.66 | — | $0 | 3 | 2023-06-23 |
| Zyla Life Sciences (EGLT) Delisted | Director | — | — | — | $0 | 1 | 2018-07-02 |
| Aravive, Inc. (VSAR) Delisted | Director | 22,280 | — | — | -$20.8K | 6 | 2017-12-22 |
| XOMA | CEO | 5,995 | $41.79 | $250.5K | -$2.47M | 41 | 2017-05-22 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | COO & CFO | — | — | — | $0 | 3 | 2010-03-01 |
Recent Filings
68 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-09 | SLS | Grant (A) | +50,000 | $0 | EDGAR |
| 2025-01-14 | SLS | Grant (A) | +12,500 | $0 | EDGAR |
| 2024-01-25 | SLS | Grant (A) | +6,000 | $0 | EDGAR |
| 2023-06-23 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-03 | SLS | Grant (A) | +2,500 | $0 | EDGAR |
| 2023-01-04 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-01 | SLS | Grant (A) | +1,900 | $0 | EDGAR |
| 2022-01-04 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-08 | SLS | Grant (A) | — | $0 | EDGAR |
| 2020-03-16 | SLS | Grant (A) | — | $0 | EDGAR |